Back to top
Intro donation


à la recherche sur le cancer

Contribuer à la recherche sur le cancer :

Contribuer à la recherche sur le cancer :

Don ponctuel
Don mensuel
Punctual donation buttons
The aim of the ERA-NET TRANSCAN 3 network is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research.

In 2023, the European partners launch a third Joint Transnational Call for Proposals (JTC 2023) that focuses on:

" Translational research on cancer epigenetics"

The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics.

In the context of translational cancer research, this call for proposals comprises two specific aims:

  1. Validation of novel epigenetics-based biomarkers to improve detection, diagnosis, prognosis of cancers or response to therapies.
  2. Validation of new epigenetics-based therapeutic strategies to limit cancer progression, prevent relapse/recurrence or increase the efficiency or reduce toxicity of existing anti-cancer therapies.


Planned launch of the call: May 9, 2023

Submission deadline for pre-proposals: July 2023

Submission deadline for full proposals: December 2023

For more information :

For more information about TRANSCAN-3 partnership : 


By email:

Contenus en lien avec cet article